Cargando…
Differences in Charge Distribution in Leishmania tarentolae Leishmanolysin Result in a Reduced Enzymatic Activity
Leishmania tarentolae is a non-pathogenic trypanosomatid isolated from lizards widely used for heterologous protein expression and extensively studied to understand the pathogenic mechanisms of leishmaniasis. The repertoire of leishmanolysin genes was reported to be expanded in L. tarentolae genome,...
Autores principales: | Ennes-Vidal, Vítor, Antunes, Deborah, Poláková, Ester, Yurchenko, Vyacheslav, Oliveira, Simone S. C., Faria da Mota, Fabio, Guimaraes, Ana Carolina R., Caffarena, Ernesto R., S. Santos, André L., Branquinha, Marta H., d’Avila-Levy, Claudia M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9321319/ https://www.ncbi.nlm.nih.gov/pubmed/35887004 http://dx.doi.org/10.3390/ijms23147660 |
Ejemplares similares
-
Structural insights into leishmanolysins encoded on chromosome 10 of Leishmania (Viannia) braziliensis
por: Sutter, Amanda, et al.
Publicado: (2017) -
ACRIFLAVIN RESISTANCE IN THE HEMOFLAGELLATE, LEISHMANIA TARENTOLAE
por: Strauss, Phyllis R.
Publicado: (1972) -
Homology Modeling of Leishmanolysin (gp63) from Leishmania
panamensis and Molecular Docking of Flavonoids
por: Mercado-Camargo, Jairo, et al.
Publicado: (2020) -
The Diverse Calpain Family in Trypanosomatidae: Functional Proteins Devoid of Proteolytic Activity?
por: Ennes-Vidal, Vítor, et al.
Publicado: (2021) -
Proteolytic inhibitors as alternative medicines to treat trypanosomatid-caused diseases: experience with calpain inhibitors
por: Ennes-Vidal, Vítor, et al.
Publicado: (2022)